The KVβ.2 inhibitors constitute a chemical class encompassing compounds that exert direct or indirect influence on the activity of the KVβ.2 subunit, an indispensable constituent of voltage-gated potassium channels. Direct inhibitors, exemplified by 4-Aminopyridine and Tetraethylammonium (TEA), operate through the occlusion of the potassium channel pore, effectively impeding ion flux and thereby impacting cellular excitability. The mechanistic precision of these direct inhibitors affords a targeted modulatory approach tailored to the intricate functional dynamics of KVβ.2, with ramifications extending to neurological disorders associated with perturbed potassium channel function. Conversely, indirect inhibitors such as Margatoxin and 1-Ethyl-2-benzimidazolinone employ a distinctive strategy by selectively modulating the activity of interconnected potassium channels associated with KVβ.2. This nuanced form of modulation elucidates the complex interplay existing among potassium channels, imparting an intricate influence on membrane potential and neuronal excitability. The indirect inhibitors thus furnish a refined avenue for the regulation of KVβ.2, accentuating the interconnected nature of potassium channels and offering prospective avenues for precise interventions in conditions characterized by aberrant potassium channel function. The diverse spectrum of KVβ.2 inhibitors, spanning both direct and indirect modalities, furnishes a panoramic understanding of potential regulators embedded within the labyrinthine network of cellular pathways governing potassium channel activity.
The comprehension of these intricate interactions assumes paramount importance for a thorough exploration of the regulatory mechanisms governing KVβ.2 within the multifaceted landscape of cellular processes. This detailed understanding not only enhances our grasp of the fundamental principles underpinning potassium channel regulation but also lays the foundation for further investigations into the nuanced orchestration of cellular signaling events governed by KVβ.2 and its associated channels. In dissecting these intricate molecular interactions, the scientific community can unravel the subtleties of potassium channel regulation, opening avenues for the development of targeted interventions, though the focus herein remains steadfastly on the elucidation of underlying molecular mechanisms.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
4-Aminopyridine | 504-24-5 | sc-202421 sc-202421B sc-202421A | 25 g 1 kg 100 g | $37.00 $1132.00 $120.00 | 3 | |
4-Aminopyridine, a potassium channel blocker, directly inhibits KVβ.2 by blocking the potassium channel pore. By impeding ion flux through the channel, it disrupts KVβ.2 function, influencing membrane potential and neuronal excitability. This direct inhibition provides a targeted approach to modulate KVβ.2 activity, offering potential therapeutic avenues for neurological disorders associated with altered potassium channel function. | ||||||
1-EBIO | 10045-45-1 | sc-201695 sc-201695A | 10 mg 50 mg | $87.00 $325.00 | 1 | |
1-Ethyl-2-benzimidazolinone, a selective KV1 channel opener, indirectly influences KVβ.2 by promoting the activity of specific potassium channels. By enhancing KV1 channel function, it indirectly modulates KVβ.2, potentially affecting neuronal excitability. This indirect modulation presents a unique approach to regulate KVβ.2 activity, emphasizing the importance of channel interactions in shaping cellular responses and suggesting potential therapeutic strategies for conditions associated with altered potassium channel function. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $27.00 $52.00 | 37 | |
2-Aminoethoxydiphenyl Borate, an IP3 receptor modulator, indirectly influences KVβ.2 by impacting intracellular calcium signaling. By modulating IP3 receptors, it indirectly modulates KVβ.2 function, potentially affecting neuronal excitability. This indirect modulation reveals a link between calcium signaling and potassium channel activity, presenting a novel avenue to regulate KVβ.2 and offering insights into potential therapeutic strategies for conditions involving altered potassium channel function and disrupted calcium homeostasis. | ||||||
Charybdotoxin | 95751-30-7 | sc-200979 | 100 µg | $401.00 | 9 | |
Charybdotoxin, a potent KV channel blocker, indirectly influences KVβ.2 by targeting specific potassium channels. By inhibiting KV channels, it indirectly modulates KVβ.2 function, impacting membrane potential and neuronal excitability. | ||||||
Chlorzoxazone | 95-25-0 | sc-211078 | 10 mg | $61.00 | ||
Chlorzoxazone, a calcium channel modulator, indirectly influences KVβ.2 by impacting intracellular calcium levels. By modulating calcium channels, it indirectly modulates KVβ.2 function, potentially affecting neuronal excitability. This indirect modulation reveals a connection between calcium signaling and potassium channel activity, offering a novel avenue to regulate KVβ.2 and providing insights into potential therapeutic strategies for conditions involving altered potassium channel function and disrupted calcium homeostasis. | ||||||